Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Manya Wu"'
Publikováno v:
Journal of Investigative Surgery, Vol 35, Iss 2, Pp 330-346 (2022)
Objective: Pancreatic cancer (PC) is an extremely malignant tumor with similar morbidity and mortality and lack of an effective treatment. This study explored the prognostic value and molecular mechanisms of proteasome 26S subunit, non-ATPase (PSMD)
Externí odkaz:
https://doaj.org/article/91a3896ac3564e01b12b949c29687d7f
Publikováno v:
PeerJ, Vol 10, p e13748 (2022)
Objective This study aimed to identify the effects of beamlet width on dynamic intensity-modulated radiation therapy (IMRT) for nasopharyngeal carcinoma (NPC) and determine the optimal parameters for the most effective radiotherapy plan. Methods This
Externí odkaz:
https://doaj.org/article/2363010fd0d5472e82ceedd5b8ac8465
Publikováno v:
PeerJ, Vol 8, p e8624 (2020)
As the first-line treatment, sorafenib has been used for advanced hepatocellular carcinoma (HCC), but the chemoresistance commonly restricts to the clinical efficiency. In this study, we intend to investigate the genome-wide expression pattern of lon
Externí odkaz:
https://doaj.org/article/2defab13660f4911950bbc506f150887
Autor:
Zhenghuan, Li, Manya, Wu, Fantu, Kong, Jie, Dong, Yuan, Cheng, Qinghe, Peng, Junyue, Shi, Huamei, Yan, Xiangying, Xu
Publikováno v:
In Journal of Radiation Research and Applied Sciences June 2023 16(2)
Publikováno v:
Journal of Investigative Surgery. 35:330-346
Objective: Pancreatic cancer (PC) is an extremely malignant tumor with similar morbidity and mortality and lack of an effective treatment. This study explored the prognostic value and molecular mec...
Publikováno v:
SSRN Electronic Journal.
Publikováno v:
Chemical Engineering Journal. 455:140722
Publikováno v:
PeerJ, Vol 8, p e8624 (2020)
PeerJ
PeerJ
As the first-line treatment, sorafenib has been used for advanced hepatocellular carcinoma (HCC), but the chemoresistance commonly restricts to the clinical efficiency. In this study, we intend to investigate the genome-wide expression pattern of lon
Autor:
Zhenzhen Zhan, Zhongmin Liu, Manya Wu, Likui Zhang, Hao Cao, Yali Ma, Junqi Yang, Bo Wang, Huimin Fan
Publikováno v:
Oncotarget
// Bo Wang 1, * , Likui Zhang 2, * , Hao Cao 2, * , Junqi Yang 1 , Manya Wu 1 , Yali Ma 1 , Huimin Fan 2 , Zhenzhen Zhan 1 and Zhongmin Liu 2 1 Key Laboratory of Arrhythmias of the Ministry of Education of China and Institute of Heart Failure, Shangh
Publikováno v:
Journal of Cancer
The anti-angiogenic drugs represented by sorafenib over the years have always been the first-line treatment of hepatocellular carcinoma (HCC), but the drug resistance has always been a "bottleneck" in curative effect. Recently, aberrant expression of